Optimizing Weight Loss Tracking: The Role of Mobile Body Scans in GLP-1 Treatment Plans
Prism Labs' mobile body scan technology turns any smartphone into a powerful body composition analyzer delivering medical-grade insights in seconds
Prism Labs' mobile body scan technology turns any smartphone into a powerful body composition analyzer delivering medical-grade insights in seconds
Direct-to-consumer telehealth pharmacies and digital health platforms are transforming how millions approach weight loss, metabolic health, and chronic disease management. But as competition intensifies and the cost of delivering GLP-1 therapies rises, one question looms large: How can your brand stand out, drive better outcomes, and prove real value to users and payors?
The answer lies in how you measure success. And it’s time to move beyond the bathroom scale.
GLP-1 therapies like semaglutide and tirzepatide are powerful tools, but their true impact extends beyond pounds lost. Patients, clinicians, and insurers increasingly want to see improvements in body composition—fat loss, lean mass retention, and metabolic health—not just a lower number on the scale.
Yet, the current standard for tracking progress is outdated:
Prism Labs is pioneering a new era in at-home health monitoring. Our mobile body scan technology turns any smartphone into a powerful body composition analyzer—delivering medical-grade insights in seconds, wherever your users are.
Here’s how integrating Prism Labs’ body scan can transform your business:
GLP-1 therapies are a significant investment for both providers and patients. By integrating Prism Labs’ technology, you can:
Ready to elevate your business?
Contact Prism Labs today to learn how mobile body scans can help you deliver superior outcomes and win in the next era of digital health.
The future of weight loss is personalized, visual, and data-driven. Don’t let your platform fall behind.